You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2024

Litigation Details for Symantec Corporation v. Zscaler, Inc. (D. Del. 2017)


✉ Email this page to a colleague

« Back to Dashboard


Biologic Drugs cited in Symantec Corporation v. Zscaler, Inc.
The biologic drug covered by the patent cited in this case is ⤷  Sign Up .

Details for Symantec Corporation v. Zscaler, Inc. (D. Del. 2017)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 External link to document
2017-06-22 3 ; 7,360,249 B1; 7,587,488 B2; 8,316,429 B2; 8,316,446 B1. (crb) (Entered: 06/23/2017) 22 June 2017… Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,285,658 B1; …2017 31 July 2017 1:17-cv-00806 830 Patent Plaintiff District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.